These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17113187)

  • 1. Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab.
    Hassan AS; Kaelin U; Braathen LR; Yawalkar N
    J Am Acad Dermatol; 2007 Feb; 56(2):217-21. PubMed ID: 17113187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe refractory atopic dermatitis with efalizumab.
    Farshidi A; Sadeghi P
    J Drugs Dermatol; 2006; 5(10):994-8. PubMed ID: 17373150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efalizumab for severe atopic dermatitis: a pilot study in adults.
    Takiguchi R; Tofte S; Simpson B; Harper E; Blauvelt A; Hanifin J; Simpson E
    J Am Acad Dermatol; 2007 Feb; 56(2):222-7. PubMed ID: 17097386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.
    Weinberg JM; Siegfried EC
    Arch Dermatol; 2006 May; 142(5):555-8. PubMed ID: 16702492
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-CD20 (rituximab) treatment improves atopic eczema.
    Simon D; Hösli S; Kostylina G; Yawalkar N; Simon HU
    J Allergy Clin Immunol; 2008 Jan; 121(1):122-8. PubMed ID: 18206507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus.
    Yun MY; Yang JH; Kim DK; Cheong KJ; Song HH; Kim DH; Cheong KJ; Kim YI; Shin SC
    Int Immunopharmacol; 2010 Sep; 10(9):1142-8. PubMed ID: 20621172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
    Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
    J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S
    Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
    [No Abstract]   [Full Text] [Related]  

  • 9. Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases.
    Ibler K; Dam TN; Gniadecki R; Kragballe K; Jemec GB; Agner T
    J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):837-9. PubMed ID: 19368612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunological approaches in the treatment of atopic eczema.
    Belloni B; Andres C; Ollert M; Ring J; Mempel M
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):423-7. PubMed ID: 18769195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab in recalcitrant severe atopic eczema associated with contact allergy.
    Cassano N; Loconsole F; Coviello C; Vena GA
    Int J Immunopathol Pharmacol; 2006; 19(1):237-40. PubMed ID: 16569363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recalcitrant atopic dermatitis with omalizumab.
    Lane JE; Cheyney JM; Lane TN; Kent DE; Cohen DJ
    J Am Acad Dermatol; 2006 Jan; 54(1):68-72. PubMed ID: 16384758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics in atopic dermatitis.
    Taïeb A; Seneschal J; Mossalayi MD
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):174-8. PubMed ID: 21812930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triderm in the treatment of atopic dermatitis].
    Kaliuzhnaia DD
    Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-CD20 (rituximab) treatment for atopic eczema.
    Sedivá A; Kayserová J; Vernerová E; Poloucková A; Capková S; Spísek R; Bartůnková J
    J Allergy Clin Immunol; 2008 Jun; 121(6):1515-6; author reply 1516-7. PubMed ID: 18410962
    [No Abstract]   [Full Text] [Related]  

  • 16. Efalizumab.
    Chacko M; Weinberg JM
    Dermatol Ther; 2007; 20(4):265-9. PubMed ID: 17970891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfalls.
    Reiger M; Traidl-Hoffmann C; Neumann AU
    J Allergy Clin Immunol; 2020 Jan; 145(1):93-96. PubMed ID: 31910987
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of T-lineage early developmental markers by cells establishing atopic dermatitis skin infiltrates.
    Mastrandrea F; Cadario G; Bedello PG; Nicotra MR; Natali PG
    J Investig Allergol Clin Immunol; 1998; 8(6):359-64. PubMed ID: 10028483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe atopic dermatitis. Antibodies revolutionize therapy].
    MMW Fortschr Med; 2015 Oct; 157(18):18. PubMed ID: 26985486
    [No Abstract]   [Full Text] [Related]  

  • 20. Atopic dermatitis/atopic eczema.
    Wallach D; Taïeb A
    Chem Immunol Allergy; 2014; 100():81-96. PubMed ID: 24925387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.